| Literature DB >> 31341546 |
Chidozie E Mbada1,2, Mistura I Olaoye1, Olumide O Dada3, Olusola Ayanniyi3, Olubusola E Johnson1, Adesola C Odole3, Gambo P Ishaya4, Oluwatosin J Omole1, Moses O Makinde1.
Abstract
Studies on validation of telerehabilitation as an effective platform to help manage as well as reduce burden of care for Low-Back Pain (LBP) are sparse. This study compared the effects of Telerehabilitation-Based McKenzie Therapy (TBMT) and Clinic-Based McKenzie Therapy (CBMT) among patients with LBP. Forty-seven consenting patients with chronic LBP who demonstrated 'directional preference' for McKenzie Extension Protocol (MEP) completed this quasi experimental study. The participants were assigned into either the CBMT or TBMT group using block permuted randomization. Participants in the CBMT and TBMT groups received MEP involving a specific sequence of lumbosacral repeated movements in extension aimed to centralize, decrease, or abolish symptoms, thrice weekly for eight weeks. TBMT is a comparable version of CBMT performed in the home with the assistance of a mobile phone app. Outcomes were assessed at the 4th and 8th weeks of the study in terms of Pain Intensity (PI), Back Extensors Muscles' Endurance (BEME), Activity Limitation (AL), Participation Restriction (PR), and General Health Status (GHS). Data were analyzed using descriptive and inferential statistics. Alpha level was set at p< 0.05. Within-group comparison across baseline, 4th and 8th weeks indicate that both CBMT and TBMT had significant effects on PI (p=0.001), BEME (p=0.001), AL (p=0.001), PR (p=0.001) and GHS (p=0.001) respectively. However, there were no significant differences (p>0.05) in the treatment effects between TBMT and CBMT, except for 'vitality' (p=0.011) scale in the GHS where TBMT led to significantly higher mean score. Mobile-app platform of the McKenzie extension protocol has comparable clinical outcomes with the traditional clinic-based McKenzie Therapy, and thus is an effective supplementary platform for care of patients with low-back pain.Entities:
Keywords: Low-Back Pain; McKenzie Therapy; Mobile-App; Nigeria; Telerehabilitation
Year: 2019 PMID: 31341546 PMCID: PMC6597146 DOI: 10.5195/ijt.2019.6260
Source DB: PubMed Journal: Int J Telerehabil ISSN: 1945-2020
Figure 1CONSORT showing the progression of patients through the study.
Figure 2User Interface skin of the TBMT app.
Figure 5McKenzie extension exercise 3.
Independent t-test Comparison of the Participants’ General Characteristics by Treatment Groups
| CBMT | TBMT | All participant | |||
|---|---|---|---|---|---|
| Variable | (n = 26) | (n = 21) | t-cal | (n = 47) | χ̄ ± SD |
| Age (y) | 50.0 ± 10.7 | 47.3 ± 11.6 | 0.845 | 0.403 | 48.8 ± 11.1 |
| Weight (Kg) | 71.0 ± 7.84 | 79.1 ± 13.1 | −2.639 | 0.011 | 74.6 ± 11.2 |
| Height (m) | 1.64 ± 0.08 | 1.68 ± 0.08 | −1.644 | 0.107 | 1.66 ± 0.08 |
| BMI (Kg/m2) | 26.4 ± 3.42 | 27.9 ± 3.65 | −1.447 | 0.155 | 27.1 ± 3.56 |
| Pain duration (month) | 8.31 ± 3.20 | 9.76 ± 2.70 | −1.660 | 0.104 | 8.96 ± 3.04 |
Alpha level was set at p <0.05; Key: CBMT = Clinic-Based McKenzie Therapy Group; TBMT = Telerehabilitation-Based McKenzie Therapy Group; x̄ = Mean; SD = Standard deviation
Participants’ profile based on the McKenzie Institute Lumbar Spine Assessment Format
| Variable | CBMT (n=26) | TBMT (n=21) | χ2 | p-value |
|---|---|---|---|---|
| Gender | ||||
| Male | 6(23.1%) | 7(33.3) | 0.611 | 0.435 |
| Female | 20(76.9%) | 14(66.7) | ||
| Occupation | ||||
| Artisan | 4(15.4%) | 2(9.52%) | 6.772 | 0.453 |
| Trading | 9(34.6%) | 4(19.05%) | ||
| Civil service | 4(15.4%) | 7(33.33%) | ||
| Teaching | 5(19.2%) | 2(9.52%) | ||
| Nursing | 1(3.85%) | 2(9.52 %) | ||
| Student | 0(0.0%) | 1(4.76 %) | ||
| Retiree | 2(7.69%) | 3(14.3%) | ||
| Driver | 1(3.85%) | 0(0.00%) | ||
| Reduced ROM | ||||
| Extension | 1(3.85%) | 0(0.00%) | 3.719 | 0.293 |
| Flexion | 2(7.69%) | 0(0.00%) | ||
| Right side flexion | 0(0.00%) | 1(4.76%) | ||
| Nil | 23(88.5%) | 20(95.2%) | ||
| Cause | ||||
| Bending | 2(7.69%) | 1(4.56%) | 10.251 | 0.114 |
| Rigorous activity | 8(30.8%) | 0(0.00%) | ||
| Lifting | 2(7.69%) | 3(14.3%) | ||
| Poor posture | 2(7.69%) | 2(9.52%) | ||
| Prolonged sitting | 3(11.5%) | 1(4.76%) | ||
| Standing | 1(3.85%) | 2(9.52%) | ||
| No apparent reason | 8(30.8%) | 12(57.1%) | ||
| Aggravating factors | ||||
| Bending | 9(34.6%) | 6(28.5%) | 1.867 | 0.867 |
| Lying | 1(3.85%) | 0(0.00%) | ||
| Sitting/rising | 4(15.4%) | 2(9.52%) | ||
| Sitting | 4(15.4%) | 4(19.0%) | ||
| Standing | 4(15.4%) | 5(23.8%) | ||
| Walking | 4(15.4%) | 4(19.0%) | ||
| Alleviating factors | ||||
| Lying | 16(61.5%) | 8(38.1%) | 3.980 | 0.409 |
| Sitting | 6(23.1%) | 9(42.9%) | ||
| Standing | 1(3.84%) | 1(4.76%) | ||
| Walking | 3(11.5%) | 2(9.52%) | ||
| Altering assumed positions | 0(0.00%) | 1((4.76%) | ||
| LBP disturbs sleep | ||||
| Yes | 13(50.0%) | 13(61.9%) | 0.666 | 0.414 |
| No | 13(50.0%) | 8(38.1%) | ||
Key: ROM = Range of Motion; % = Percentage; CBMT = Clinic-Based McKenzie Therapy; TBMT = Telerehabilitation-Based McKenzie Therapy
Comparison of the Participants’ Baseline Parameters
| Variable | CBMT (n=26) | TBMT (n=21) | Statistics | p-value |
|---|---|---|---|---|
| χ̄±SD | χ̄±SD | t | ||
| Pain intensity | ||||
| Current | 5.00 ± 1.96 | 4.29 ± 1.38 | 1.409 | 0.166 |
| Average | 5.31 ± 1.44 | 4.95 ± 0.92 | 0.982 | 0.332 |
| Least | 2.62 ± 1.27 | 2.76 ± 1.41 | −0.375 | 0.710 |
| Worst | 7.08 ± 1.41 | 7.24 ± 1.00 | 0.442 | 0.661 |
| QVAS score | 58.0± 14.1 | 54.9 ± 8.67 | 0.863 | 0.393 |
| Activity limitation | 11.8 ± 4.78 | 10.2 ± 4.66 | 1.133 | 0.263 |
| Back muscles endurance | 20.4 ±12.8 | 25.8 ± 15.2 | −1.319 | 0.194 |
| General health status | ||||
| Physical function | 26.3±22.7 | 30.9±24.3 | 0.979 | 0.500 |
| Role Limitation-physical | 97.3± 9.51 | 93.3± 14.1 | 1.151 | 0.256 |
| Bodily Pain | 58.7± 24.1 | 67.7±16.6 | 1.447 | 0.155 |
| Health Perception | 40.4± 26.0 | 38.3± 17.4 | 0.310 | 0.758 |
| Energy/Vitality | 41.5± 23.3 | 61.0± 23.2 | 2.846 | 0.007 |
| Social Functioning | 90.4± 12.4 | 83.3±12.1 | 1.960 | 0.056 |
| Role Limitation – emotional | 94.6± 12.8 | 86.7±17.4 | 1.798 | 0.079 |
| Mental Health | 53.1± 13.7 | 58.2± 15.3 | 1.213 | 0.231 |
| Mental Health | 69.9±8.71 | 72.3 ± 5.74 | 1.080 | 0.286 |
| Physical Health | 64.2± 10.4 | 65.9±4.68 | 0.701 | 0.487 |
| Mean rank | Mean rank | U | ||
| Participation restriction | 24.1 | 23.9 | 271.500 | 0.974 |
Key: χ̄ = Mean; SD = Standard Deviation; QVAS = Quadruple Visual Analogue Scale
Parametric test - Independent t-test;
Non-Parametric test - Mann-Whitney U
Comparisons of Treatment Outcomes among Participants in CBMT across the Three Time Points of the Study (n=26)
| Variable | Baseline | 4th week | 8th week | Statistics | p-value |
|---|---|---|---|---|---|
| χ̄±SD | χ̄±SD | χ̄±SD | F | ||
| Pain intensity | |||||
| Current | 5.00 ± 1.96a | 3.42 ± 0.86b | 1.54 ± 1.24c | 58.798 | 0.001 |
| Average | 5.31 ± 1.44a | 3.46 ± 1.07b | 1.77 ± 0.91c | 139.21 | 0.001 |
| Least | 2.62 ± 1.27a | 1.23 ± 1.07b | 0.35 ± 0.69c | 85.571 | 0.001 |
| Worst | 7.08 ± 1.41a | 4.58 ± 1.17b | 3.04 ± 1.08c | 163.188 | 0.001 |
| QVAS score | 57.9 ± 14.0a | 38.2 ± 8.12b | 21.2 ± 9.66c | 138.715 | 0.001 |
| Activity limitation | 11.8 ± 4.78a | 6.38 ± 3.02b | 2.50 ± 1.72c | 125.265 | 0.001 |
| Back muscles endurance | 20.4 ± 12.8a | 29.1 ± 12.8a | 35.4 ± 11.4b | 101.397 | 0.001 |
| General health status | |||||
| Physical Functioning | 22.3±22.7 | 58.3±21.2 | 69.9±18.3 | 76.455 | 0.001 |
| Role Limitation-physical | 97.3 ±9.51a | 77.1 ± 9.00b | 89.2 ± 16.5c | 7.500 | 0.011 |
| Bodily Pain | 58.7 ± 24.1a | 79.0 ± 13.5b | 89.5 ± 14.5b | 26.543 | 0.001 |
| Health Perception | 40.4 ± 26.0a | 71.0 ± 26.0a | 82.7 ± 14.1 | 67.957 | 0.001 |
| Energy/Vitality | 94.6 ± 12.8a | 70.4 ± 12.8a | 69.0 ± 11.4b | 67.857 | 0.001 |
| Social Functioning | 90.4 ± 12.4a | 78.8 ± 9.20 b | 76.9 ± 6.79b | 29.167 | 0.001 |
| Role Limitation-emotional | 94.6 ± 12.9a | 70.4 ± 12.9b | 69.0± 11.4 | 67.857 | 0.001 |
| Mental Health | 70.8 ±13.7a | 65.9 ± 13.6b | 70.8 ± 4.25c | 37.559 | 0.001 |
| Mental Health | 69.9 ± 8.70a | 71.9 ± 7.38b | 75.9 ± 6.42c | 11.747 | 0.001 |
| Physical Health | 64.2 ± 10.4a | 72.4 ± 7.32a | 80.1 ± 7.04b | 41.684 | 0.001 |
| Mean rank | Mean rank | Mean rank | χ2 | ||
| Participation restriction | 24.1a | 26.1b | 25.0c | 59.769 | 0.001 |
Parametric test - ANOVA (F-ratio) and LSD post-hoc multiple comparison;
Non-Parametric test - Friedman’s ANOVA (χ2) and Wilcoxon signed ranked test
Superscripts (). For a particular variable, mean values with different superscript are significantly (p<0.05) different. Mean values with same superscripts are not significantly (p>0.05) different. The pair of mean values that are significantly different have different superscripts assigned to them.
Key: χ̄ = Mean; SD = Standard Deviation; QVAS = Quadruple Visual Analogue Scale
Comparisons of Treatment Outcomes among Participants in TBMT across the Three Time Points of the Study (n=21)
| Baseline | 4th week | 8th week | |||
|---|---|---|---|---|---|
|
| |||||
| Variable | χ̄±SD | χ̄±SD | χ̄±SD | Statistics | p-value |
| χ̄±SD | χ̄±SD | χ̄±SD | F | ||
| Pain intensity | |||||
| Current | 4.29 ± 1.38a | 2.43± 1.25b | 0.48 ± 0.51c | 183.381 | 0.001 |
| Average | 4.95 ± 0.92a | 3.00 ± 0.71b | 0.76± 0.94c | 317.377 | 0.001 |
| Least | 2.76 ± 1.41a | 0.67 ± 0.91b | 0.10 ± 0.30c | 70.000 | 0.001 |
| Worst | 7.24 ± 1.00a | 4.48 ± 1.21b | 1.95 ± 1.56c | 243.018 | 0.001 |
| QVAS score | 54.9 ± 8.67a | 33.0 ± 6.74b | 10.6 ± 7.86c | 521.024 | 0.001 |
| Activity limitation | 10.2 ± 4.66a | 5.38 ± 3.14b | 2.29 ± 2.47c | 78.362 | 0.001 |
| Back muscles endurance | 25.8 ± 15.2a | 35.5 ± 15.0a | 40.1 ± 13.6b | 97.815 | 0.001 |
| General health status | |||||
| Physical Functioning | 30.9 ± 24.3a | 61.1 ± 21.3b | 74.6 ± 16.3c | 58.852 | 0.001 |
| Role Limitation – Physical | 25.8 ± 14.1a | 83.3 ± 17.9b | 90.0 ± 16.2c | 0.488 | 0.493 |
| Bodily Pain | 67.6 ± 16.6a | 76.2 ± 22.7 | 89.5 ± 10.9c | 39.331 | 0.001 |
| Health Perception | 38.3 ± 17.5a | 74.3 ± 16.6b | 78.2 ± 16.3c | 60.235 | 0.001 |
| Energy/Vitality | 60.9 ± 23.2a | 81.9 ± 18.9b | 82.9 ± 19.3b | 12.050 | 0.002 |
| Social Functioning | 83.3 ± 12.1a | 77.4 ± 7.52b | 75.0 ± 10.3b | 10.000 | 0.005 |
| Role Limitation –Emotional | 86.7 ± 17.4a | 66.7 ± 7.64b | 66.7 ± 10.3b | 26.667 | 0.001 |
| Mental Health | 58.2 ± 15.3a | 66.0 ± 7.23b | 68.3 ± 5.12c | 9.510 | 0.006 |
| Mental Health | 72.3 ± 5.73a | 73.0 ± 4.64b | 73.2 ± 4.46c | 9.510 | 0.006 |
| Physical Health | 65.8 ± 4.68a | 74.4 ± 7.48b | 79.5 ± 6.48c | 70.028 | 0.001 |
| Mean rank | Mean rank | Mean rank | χ2 | ||
| Participation restriction | 23.9a | 21.4b | 22.8c | 131.236 | 0.001 |
Parametric test - ANOVA (F-ratio) and LSD post-hoc multiple comparison;
Non-Parametric test - Friedman’s ANOVA (χ2) and Wilcoxon signed ranked test
Superscripts (). For a particular variable, mean values with different superscript are significantly (p<0.05) different. Mean values with same superscripts are not significantly (p>0.05) different. The pair of mean values that are significantly different have different superscripts assigned to them.
Key: χ̄ = Mean; SD = Standard Deviation; QVAS = Quadruple Visual Analogue Scale
Comparison of Participants’ Treatment Outcomes (Mean Change) for the Continuous Variables at Week 4 of the Study
| Variable | CBMT (n=26) | TBMT (n=21) | Statistics | p-value |
|---|---|---|---|---|
| χ̄±SD | χ̄±SD | t | ||
| Pain intensity | ||||
| Current | 1.58 ± 1.50 | 1.86 ± 0.79 | −0.772 | 0.444 |
| Average | 1.85 ± 1.43 | 1.95 ± 0.74 | −0.308 | 0.760 |
| Least | 1.39 ± 0.98 | 2.10 ± 1.55 | −1.915 | 0.062 |
| Worst | 2.50 ± 1.55 | 2.76 ± 1.34 | −0.610 | 0.545 |
| QVAS score | 19.7± 12.3 | 21.9± 7.57 | −0.706 | 0.484 |
| Activity limitation | 5.42 ± 3.04 | 4.86 ± 4.53 | 0.511 | 0.612 |
| Back muscles endurance | 8.69 ± 5.73 | 9.71 ± 6.38 | −0.578 | 0.566 |
| General health status | ||||
| Physical Functioning | 32.0 ± 27.9 | 30.1 ± 31.9 | 0.217 | 0.829 |
| Role Limitation - Physical | 20.2 ± 17.6 | 10.0 ± 22.5 | 1.741 | 0.089 |
| Bodily Pain | 20.3 ± 22.5 | 8.57 ± 25.5 | ||
| Health Perception | 30.6 ± 37.2 | 35.9 ± 25.2 | 0.565 | 0.575 |
| Energy/Vitality | 30.7 ± 23.5 | 20.9 ± 27.9 | 1.310 | 0.197 |
| Social Functioning | 11.5 ± 12.7 | 5.95 ± 10.9 | 1.594 | 0.118 |
| Role Limitation – Emotional | 24.2 ± 19.2 | 20.0 ± 17.7 | 0.776 | 0.442 |
| Mental Health | 12.9 ± 14.4 | 7.82 ± 17.3 | ||
| Mental Health | 1.95 ± 7.92 | 0.71 ± 7.46 | 0.552 | 0.584 |
| Physical Health | 8.26 ± 10.2 | 8.52 ± 10.0 | 0.090 | 0.929 |
| Mean rank | Mean rank | U | ||
| Participation restriction | 26.4 | 21.0 | 210.000 | 0.176 |
Key: χ̄ = Mean; SD = Standard Deviation; QVAS = Quadruple Visual Analogue Scale
Parametric test - Independent t-test;
Non-Parametric test - Mann-Whitney U test
Comparison of Participants’ Treatment Outcomes (Mean Change – i.e., Week Eight minus Baseline) for the Continuous Variables at Week 8 of the Study
| Variable | CBMT (n=26) | TBMT (n=21) | Statistics | p-value |
|---|---|---|---|---|
| χ̄±SD | χ̄±SD | t | ||
| Pain intensity | ||||
| Current | 3.46± 2.30 | 3.89 ± 1.29 | 0.618 | 0.540 |
| Average | 3.53 ± 1.52 | 4.19 ± 1.08 | 0.982 | 0.332 |
| Least | 2.27 ± 1.25 | 2.67 ± 1.46 | −0.375 | 0.710 |
| Worst | 4.04 ± 1.61 | 5.29 ± 1.55 | −0.442 | 0.661 |
| QVAS score | 36.8 ± 15.9 | 44.3 ± 8.89 | 0.863 | 0.393 |
| Activity limitation | 9.31 ± 4.24 | 7.95 ± 4.12 | 1.104 | 0.276 |
| Back muscles endurance | 15.0 ± 7.58 | 14.3 ± 6.62 | 0.321 | 0.749 |
| General health status | ||||
| Physical Functioning | 43.6 ± 25.4 | 43.7 ± 26.1 | 0.008 | 0.994 |
| Role Limitation - Physical | 8.08 ± 15.0 | 3.33 ± 21.9 | 0.879 | 0.384 |
| Bodily Pain | 27.3 ± 27.0 | 21.9 ± 16.0 | 0.808 | 0.423 |
| Health Perception | 42.3 ± 32.5 | 39.8 ± 23.5 | 0.301 | 0.765 |
| Energy/Vitality | 45.4 ± 31.3 | 21.9 ± 28.9 | 2.646 | 0.011 |
| Social Functioning | 13.5 ± 12.7 | 8.33 ± 12.1 | 1.406 | 0.167 |
| Role Limitation - Emotional | 25.6 ± 15.8 | 20.0 ± 17.7 | 1.137 | 0.261 |
| Mental Health | 17.7 ± 14.7 | 10.0 ± 14.9 | ||
| Mental Health | 6.01 ± 8.94 | 0.901 ± 8.48 | ||
| Physical Health | 15.9 ± 12.6 | 13.7 ± 7.47 | 0.730 | 0.469 |
| Mean rank | Mean rank | U | ||
| Participation restriction | 25.6 | 22.1 | 232.000 | 0.380 |
Key: x̄ = Mean; SD = Standard Deviation; QVAS = Quadruple Visual Analogue Scale
Parametric test - Independent t-test;
Non-Parametric - Mann-Whitney U test